Health Catalyst Reports Third Quarter 2025 Results

Core Insights - Health Catalyst reported total revenue of $76.3 million for Q3 2025, slightly down from $76.4 million in Q3 2024, but achieved an Adjusted EBITDA of $12.0 million, a 64% increase year-over-year [2][3][4] Financial Performance - Total revenue for the three months ended September 30, 2025, was $76,323,000, compared to $76,353,000 in the same period of 2024, reflecting a negligible change of —% [3] - Gross profit increased to $29,979,000, up 8% from $27,758,000 in Q3 2024, resulting in a gross margin of 39% compared to 36% a year earlier [3] - The company reported a net loss of $22,229,000 for Q3 2025, which is a 51% increase from the net loss of $14,726,000 in Q3 2024 [3] - Adjusted Gross Profit for Q3 2025 was $40,133,000, an 11% increase from $36,289,000 in Q3 2024, with an Adjusted Gross Margin of 53% compared to 48% in the prior year [3][22] - Adjusted EBITDA for Q3 2025 was $12,000,000, significantly higher than $7,295,000 in Q3 2024 [3][33] Financial Outlook - The company reaffirmed its full-year 2025 guidance, expecting total revenue of approximately $310 million and Adjusted EBITDA of approximately $41 million [4][5] Company Overview - Health Catalyst is a leading provider of data and analytics technology and services for healthcare organizations, with over 1,100 clients globally [7] - The company focuses on high-impact solutions that demonstrate proven ROI, aiming to drive sustained value for clients and shareholders [2][7]